| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criterion 6. See AWMSG criteria for appraising a medicine for information. |
|
Medicine details |
|
| Medicine name | misoprostol (Angusta®) |
| Formulation | 25 microgram tablet |
| Reference number | 4624 |
| Indication | Induction of labour |
| Company | Norgine Pharmaceuticals Ltd |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 07/04/2021 |